Li‐Fan Zeng

1.8k total citations
43 papers, 1.4k citations indexed

About

Li‐Fan Zeng is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Li‐Fan Zeng has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 16 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Li‐Fan Zeng's work include Protein Tyrosine Phosphatases (20 papers), Galectins and Cancer Biology (11 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Li‐Fan Zeng is often cited by papers focused on Protein Tyrosine Phosphatases (20 papers), Galectins and Cancer Biology (11 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Li‐Fan Zeng collaborates with scholars based in United States, China and United Kingdom. Li‐Fan Zeng's co-authors include Yantao He, Zhong‐Yin Zhang, Rongjun He, Edward J. Goetzl, Songzhu An, Andrea Gunawan, Zhong-Yin Zhang, Zhi-Hong Yu, Ya-Qiu Long and Zhong‐Yin Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Investigation.

In The Last Decade

Li‐Fan Zeng

43 papers receiving 1.4k citations

Peers

Li‐Fan Zeng
Comparison fields: 5 of 94
  • Molecular Biology 1.0k
  • Immunology 536
  • Oncology 252
  • Organic Chemistry 190
  • Toxicology 130
Replace Yantao He with:
Yantao He United States
Hidesuke Fukazawa Japan
Grazia Gallo Italy
Alison Maloney United Kingdom
Sijiu Liu United States
Hariprasad Vankayalapati United States
Jakob Fuhrmann United States
George W. Small United States
Christian Grütter Germany
Pierre Beauparlant Canada
Yantao He United States View profile →
Citations per field, relative to Li‐Fan Zeng
Li‐Fan Zeng · 1×
Citations per year, relative to Li‐Fan Zeng
Li‐Fan Zeng · 1×

Countries citing papers authored by Li‐Fan Zeng

Since Specialization
Citations

This map shows the geographic impact of Li‐Fan Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Fan Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Fan Zeng more than expected).

Fields of papers citing papers by Li‐Fan Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Fan Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Fan Zeng. The network helps show where Li‐Fan Zeng may publish in the future.

Co-authorship network of co-authors of Li‐Fan Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Fan Zeng. A scholar is included among the top collaborators of Li‐Fan Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Fan Zeng. Li‐Fan Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 3
3 17
4 14
5 47
6 27
7
Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers
1
8 35
9
Novel anticancer agents based on targeting the trimer interface of the PRL phosphatase
1
10 42
11 182
12 43
13
Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
1
14 19
15 22
16 111
17 35
18 38
19 18
20 38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026